Centa Longevity
Longevity clinic using multimodal biomarkers to assess and treat biological aging.
Company Overview
Snapshot
Founded in December 2025, Centa Longevity operates with 1–10 employees. The company is currently in the Pre-Funding stage.
Business overview
Centa Longevity is an Israeli longevity clinic and aging research company specializing in advanced diagnostics and treatments for biological age. The company utilizes a multimodal approach, combining molecular, serum, imaging, and functional measurements to create detailed biological age profiles based on hundreds of biomarkers. Proprietary algorithms analyze this data to identify risk factors and guide personalized prevention and rejuvenation programs. Centa Longevity offers evidence-based, clinically vetted interventions across preventative, functional, and molecular domains, aiming to reduce disease risk and extend the healthy lifespan of its clients. It operates within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Digital Medical Diagnostics, serving B2C markets.
Log in to access full profile ›Company Intelligence Q&A
- What is Centa Longevity's primary focus?
- Centa Longevity is an Israeli longevity clinic and aging research company focused on assessing and treating biological aging through advanced diagnostics and personalized interventions.
- When was Centa Longevity founded?
- Centa Longevity was founded in December 2025.
- What kind of approach does Centa Longevity use for biological age assessment?
- Centa Longevity uses a multimodal approach that combines molecular, serum, imaging, and functional measurements to build detailed biological age profiles based on hundreds of biomarkers.
- What markets does Centa Longevity serve?
- Centa Longevity primarily serves B2C markets with its longevity and anti-aging solutions.